LV Management Group LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 06:35 am Purchase | 2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | LV Management Group LLC | 4,141 0.200% | 4,141 (New Position) | Filing |